We aimed to evaluate whether pericardial fat has value in predicting the risk of future adverse cardiovascular outcomes.
T he discovery that pericardial fat may locally affect coronary arterial health through generation of inflammatory cytokines has generated a great level of interest in using it to predict adverse cardiovascular events (1) . Pericardial fat can be routinely detected by noncontrast computed tomography (NCT) performed for coronary calcium scoring (CCS), potentially obviating the need for dedicated diagnostic testing. On NCT, pericardial fat volume (PFV) can be assessed by direct measurement, which depends on reliable detection of the thin pericardium. The PFV can also be assessed as a component of heart-level thoracic fat volume (TFV), whose boundaries are more robustly visualized, resulting in lower interobserver variability (2, 3) .
To date, PFV detected on computed tomography (CT) has been linked to coronary artery disease (CAD) risk factors, significant prior cardiovascular events, coronary arterial calcium, severity of detected CAD, and biochemical markers of systemic inflammation (2,4 -12) . However, whether PFV and TFV are related to the occurrence of future adverse cardiovascular outcomes has not been evaluated. A case-control study design, often used to initially assess the epidemiologic importance of potentially novel disease markers and form the basis for subsequent prospective research (13) (14) (15) , is advantageous for PFV and TFV because complete quantification of both parameters in a large population using currently available techniques would be prohibitively time and labor intensive. We thus conducted the following case-control study to evaluate whether PFV and TFV predict subsequent major adverse cardiac events (MACE).
M E T H O D S
Patient population and imaging protocol. Our study was a case-control analysis of 2,751 asymptomatic patients without known CAD enrolled in the EISNER (Early Identification of Subclinical Atherosclerosis Using Noninvasive Imaging Research) registry at Cedars-Sinai Medical Center, Los Angeles, California. Inclusion criteria for these patients were age 45 to 80 years and exhibition of intermediate pre-test probability for CAD defined by being: 1) men Ն55 years or women Ն65 years; or 2) men 45 to 54 years or women 55 to 64 years with at least 1 traditional CAD risk factor. Exclusion criteria were history of myocardial infarction, coronary revascularization, cardiomyopathy, peripheral artery disease, angina, or stroke; history of having a prior coronary calcium scan or invasive coronary angiogram; active pregnancy; clinical instability; and significant medical comorbidity likely to independently impact outcome during follow-up. Between September 1998 and May 2005, these patients underwent an index NCT to obtain a CCS and were prospectively followed for subsequent MACE (including cardiac death, myocardial infarction, stroke, and late percutaneous or surgical revascularization defined as occurring more than 6 months after NCT). The occurrence of MACE was confirmed by direct contact between research staff and patient or next of kin, followed by review of corresponding medical or death records by an independent cardiologist.
At 4 years of follow-up, 58 patients (46 men) experienced MACE, including 4 cardiac deaths, 13 nonfatal myocardial infarctions, 8 strokes, 26 late percutaneous revascularizations, and 7 late surgical revascularizations. We matched each MACE patient to 3 same-sex, event-free control subjects by using a propensity score; the technique of propensity score-based matching has been widely used to simultaneously control many confounders (16 -18 ). An overall score was first calculated for each patient using a probit model that accounted for age, body mass index (BMI), traditional risk factors (diabetes, hypertension, dyslipidemia, smoking history, and family CAD history), and logarithm-adjusted CCS (because distribution of CCS was non-normal). Each MACE patient was then matched to 3 same-sex control subjects with the closest scores. A total of 232 patients (58 MACE patients and 174 control subjects) thus comprised the study population. Framingham risk score (FRS) (19) was calculated for all patients at the time of the index NCT. This study was conducted according to guidelines of the Cedars-Sinai Medical Center Institutional Review Board. All patients provided written consent for retrospective use of their data.
The NCT was acquired using an electron-beam (e-Speed, GE Healthcare, Milwaukee, Wisconsin) or a 4-slice CT scanner (Somatom Volumezoom, Siemens Medical Solutions, Forchheim, Germany). Both scanners were calibrated daily using air and water phantoms. Each scan extended from the aortic arch to the diaphragm and was obtained during a single breath-hold. Scan parameters included heart rate-dependent electrocardiogram triggering (typically 45% to 60% of the R-R interval), 35-cm field-of-view, and 512 ϫ 512 matrix All CT images were initially reviewed by an expert reader, using semiautomatic, commercially available software (ScImage, Los Altos, California) to quantify coronary calcification. Total Agatston CCS was calculated as the sum of calcified plaque scores of all coronary arteries (20) . Acquired images were then transferred to a research workstation for pericardial and thoracic fat quantification. Pericardial and thoracic fat quantification. Definitions of pericardial and thoracic fat were based on our group's recent work (3): pericardial fat includes all adipose tissue enclosed by the visceral pericardium, including all fat directly surrounding the coronary arteries. Thoracic fat includes all adipose tissue within the chest at the level of the heart, enclosed by the posterior limit of the heart and above the diaphragm, with the same cranial and caudal boundaries defined for pericardial fat. Thoracic fat includes pericardial fat.
Pericardial and thoracic fat quantification was performed by software (QFAT) developed at the Cedars-Sinai Medical Center (3). The software can be executed on standard Microsoft Windows (Microsoft Corp., Redmond, Washington) workstations and includes algorithms for automatic thoracic cavity and heart segmentation and quantification of thoracic fat, which we have already described (21) . Image data were processed as follows. First, the upper slice limit, marked by bifurcation of the pulmonary trunk, and lower slice limit, identified as the last slice containing any portion of the heart, were manually chosen by an expert reader blinded to patient status and clinical NCT interpretation. Next, this reader defined 5 to 7 control points on the pericardium in each transverse view. From these control points, piecewise cubic Catmull-Rom spline functions (22) were automatically generated to create a smooth, closed pericardial contour (Fig. 1) . The PFV and TFV were then automatically calculated (reported in cm 3 ). Contiguous 3-dimensional voxels between the Hounsfield unit limits of Ϫ190 to Ϫ30 were defined as fat voxels by default (23) (24) (25) (26) ; these limits can be modified by the user if deemed appropriate. Statistical analysis. Distributions of CCS, PFV, and TFV as continuous variables were non-normal and were thus described as mean Ϯ SD after normalization with logarithmic adjustment. Base-2 logarithmic transformation was chosen because each unit increase represented a more easily understandable doubling of the variable in question; this approach has been adopted for CCS previously (27) . Other continuous variables were described as mean Ϯ SD. Univariate comparisons between patients experiencing MACE and control subjects At each axial slice, the reader first identifies the pericardium (Panel 1, white arrow). Five to 7 points (Panel 2, blue dots) are manually placed along the pericardial line, and a pericardial contour is then automatically generated (Panel 2). Once this task is completed for all axial slices, the software algorithm detects and quantifies all fat voxels within the pericardial contour to generate pericardial fat volume (PFV). Fat voxels outside of the pericardial contour are also detected and added to PFV to generate thoracic fat volume (TFV) (Panel 3).
Cheng et al. Pericardial Fat Burden and Adverse Outcomes were made using the Student t test or chi-square test, as appropriate. Because individual covariate differences between MACE patients and control subjects after matching by propensity score can still cause confounding, conditional multivariable logistic regression models were constructed to adjust for these differences while independent relationships were assessed among PFV, TFV, and MACE. This approach has been used previously (28, 29) . In the conditional multivariable regression models, PFV and TFV were entered into separate analyses containing age, CCS, and all traditional risk factors, and then into separate analyses containing BMI, CCS, and FRS. Model fit of the conditional logistic regression analyses was checked using the likelihood ratio test to evaluate whether addition of PFV and TFV yielded significant increases in deviance chi-square, which would suggest improved prediction of MACE. To further examine potential incremental value of PFV and TFV over established risk prediction strategies, receiver-operator characteristic (ROC) curves were constructed, and area under the curve (AUC) were compared. For all ROC analyses, FRS was a continuous variable; binary thresholds of 400 for CCS, 125 cm 3 for PFV, and 250 cm 3 for TFV were selected (PFV and TFV thresholds were found from initial comparisons between patients developing MACE and control subjects). Differences in estimated sensitivity, specificity, and accuracy were compared using the McNemar test. Associations and differences with p Ͻ 0.05 were considered significant. All statistical analyses, including propensity score-based matching as described at the beginning of the Methods section, were performed using STATA software (version 9, StataCorp LP, College Station, Texas).
R E S U L T S
Between patients experiencing MACE and matched control subjects, the mean absolute difference in propensity score was 0.035 Ϯ 0.025. Our matching technique resulted in no significant differences in age, logarithm-adjusted CCS, and prevalence of traditional risk factors between comparison groups (univariable analysis results are shown in Table 1 ). Hypercholesterolemia (66% in MACE group, 64% in control group) and hypertension (81% in MACE group, 80% in control group) were the most frequently found risk factors in both groups. Mean FRS in the MACE group was higher than that in the control group at the time of NCT (15 Ϯ 8 vs. 12 Ϯ 7, p ϭ 0.012), although both mean scores predicted intermediate risk.
Detection of pericardial and thoracic fat and quantification of PFV and TFV were successful in all cases. Analysis of the typical NCT required 5 to 10 min of user time to fully contour the pericardium. The PFV and TFV were highly correlated to each other (r 2 ϭ 0.74). Overall mean PFV was 89. Results from multivariable analyses are shown in Tables 2 and 3 . In multivariable analyses adjusted for age, CCS, and all traditional risk factors, PFV was associated with MACE (OR: 1.91, 95% CI: 1.14 to 3.19 per doubling of PFV), as was TFV (OR: 1.83, 95% CI: 1.08 to 3.09 per doubling of TFV). As expected from matching, none of the other variables showed a significant association. In multivariable analyses adjusted for BMI, CCS, and FRS, PFV (OR: 1.74, 95% CI: 1.03 to 2.95 per doubling) and TFV (OR: 1.78, 95% CI: 1.01 to 3.14 per doubling) remained significantly associated with MACE. In these analyses, FRS was a concurrent independent predictor of MACE when adjust- The ROC analysis using FRS and CCS Ն400 resulted in an AUC of 0.68; using FRS, CCS Ն400, and PFV Ն125 cm 3 resulted in an AUC of 0.73 (Fig. 4) , a difference that trended toward significance (p ϭ 0.058). The estimated sensitivity for predicting MACE when PFV Ն125 cm 3 was added to FRS and CCS Ն400 was not different than using FRS and CCS Ն400 only (0.65 vs. 0.61, p ϭ 0.48). However, the estimated specificity (0.72 vs. 0.66, p ϭ 0.009) and accuracy (0.70 vs. 0.65, p ϭ 0.009) improved. The ROC analysis using TFV Ն250 cm 3 in place of PFV did not show any significant difference (AUC 0.68 vs. 0.68, p ϭ 0.7).
D I S C U S S I O N
Our work is the first to directly evaluate the relationship among PFV, TFV, and subsequent adverse cardiovascular outcomes. In our casecontrol study, based on 4-year post-NCT follow-up in asymptomatic patients without established CAD, we found that increased PFV was independently related to MACE. Although TFV (which includes PFV) also exhibited an Within each panel, the top row shows standard coronal, axial, and sagittal (left to right) computed tomography (CT) displays of the heart, and the bottom row shows the same images with superimposed detection of pericardial fat (red) and thoracic fat (red and yellow). Top panel images are from a 58-year-old woman who underwent coronary artery bypass graft surgery for symptomatic multivessel coronary artery disease 572 days after the noncontrast CT. Her PFV was 187 cm 3 and TFV was 315 cm 3 . Bottom panel images are from a matched 56-year-old event-free woman. Her PFV was 72 cm 3 and TFV was 111 cm 3 . BMI ϭ body mass index; CCS ϭ coronary calcium score; other abbreviations as in Figure 1 .
independent relationship to MACE, a more detailed, ROC-based evaluation showed that PFV was the primarily responsible parameter. Furthermore, we found no significant relationship between extrapericardial thoracic fat volume (defined as TFV Ϫ PFV) and MACE. Therefore, the association detected between TFV and MACE was in all likelihood due to TFV's close correlation to PFV.
Our findings provide an important insight into existing evidence linking PFV to markers of cardiovascular risk. In particular, we demonstrated that the potentially confounding associations among PFV, CAD risk factors, and CCS do not sufficiently explain the relationship between PFV and MACE (2,5,6,8 -10,12) . By using a propensity score to account for the totality of these confounders and generate adequately matched cohorts, we showed that PFV provided incremental value for predicting MACE. However, despite matching MACE patients to control group with many features used to derive FRS, our models did not fully control for FRS, which remained predictive of MACE. This finding highlights the strong prognostic utility of FRS in our population. Importantly, PFV still exhibited a significant association with MACE after adjustments for FRS.
Independent prognostic value of PFV for MACE may be a clinically relevant extension of previously described findings of elevated inflammation in pericardial fat depots. Mazurek et al. (1) elegantly showed that adipose tissue adjacent to the right coronary artery contained significantly higher expression of interleukin-1␤, interleukin-6, monocyte chemotactic protein, and tumor necrosis factor, and retained a greater number of inflammatory cells than subcutaneous adipose tissue. A paracrine effect of inflammatory cytokines from pericardial adipose tissue may promote atherogenesis and lead to elevated risk of adverse coronary events, which made up the majority of MACE in our population (46 of 58 events, if death and stroke are counted as noncoronary events). By definition, PFV and TFV are dependent variables. PFV has the advantage of being a more physiologically direct disease marker; however, it has the disadvantage of dependency on clear demarcation of the thin pericardium for quantification, making it more challenging, time consuming, and potentially less reproducible to measure than TFV (3). An example of this was seen in the work by Ding et al. (9) , who measured TFV in a slab around the origin of the left main coronary in part because pericardium can be difficult to visualize in lean individuals. Mahabadi et al. (11) showed that PFV, but not intrathoracic fat (equivalent to the extrapericardial thoracic fat volume in our study), was related to the burden of prior cardiovascular disease after adjusting for age, sex, BMI, and waist circumference, suggesting that PFV may be a more specific disease marker. However, Mahabadi et al. (11) did not examine the association between TFV and cardiovascular disease burden. There is also evidence suggesting that PFV and TFV may reflect the risk of atherosclerotic disease in different regions within the body. Rosito et al. (10) showed that although PFV was associated with coronary calcification, TFV was associated with abdominal aortic calcification. Our work is the first to demonstrate that PFV is preferred over TFV when evaluating the risk of clinically important cardiovascular outcomes.
We used an automated algorithm to quantify TFV (3,21) and a semiautomated approach, over a user-selected range of the heart, to quantify PFV. Logistically, automatic quantification of TFV is significantly less time consuming (typically 20 s) and more reproducible (3). However, results from our present study suggest that fully automated algorithms for measurement of PFV can add to cardiovascular risk stratification and are needed for studying large patient cohorts. Study limitations. Our study had several limitations. The population evaluated comprised primarily individuals at low risk, and this was reflected in the modest number of adverse cardiovascular events. A case-control study design is more prone to confounding than a cohort study design; however, application of our semiquantitative technique to measure whole-heart PFV in the entire cohort would have been prohibitively time and resource intensive, as noted. We used propensity scorebased matching because simultaneous exact matching of all variables was not possible; propensity score-based matching may not be as powerful as individual variable matching in controlling for potential confounding. However, this design has been previously used with success (28, 29) . Although our results suggest additive utility of pericardial fat to traditional MACE risk-stratifying tools, confirmation through longitudinal whole-cohort evaluation Tables 1 and 2 . Asymptomatic patients who experienced MACE exhibited greater PFV on pre-MACE NCT than matched event-free control subjects with similar cardiovascular risk profiles. Our preliminary findings suggest that increased pericardial fat may help predict adverse cardiovascular outcomes.
